ProPhase Labs’ Resolution for 2025: Nail Down a ‘Liquidity Event’
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
Laboratory Industry Report
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
Subscribe today for access to
Articles and Reports
Out with the Old: The 2024 Clinical Lab Experience
What challenges and opportunities affected the experience of medical lab professionals in 2024—and what might the new year bring?
FDA Watch: How Could the Change in US Government Affect IVDs and Labs?
Experts say new leadership could impact the cost and availability of IVDs as well as patients’ ability to afford lab testing
CMS Bars Theranos’ California Lab from Medicare Program
...
Already a member? Log in here
Transgenomic Tries to Jumpstart Business Model Again
...
Already a member? Log in here
LabCorp Develops Companion Diagnostic for Roche Cancer Drug
...
Already a member? Log in here
Use of Cologuard Test Will Be Placed in 2017 HEDIS Guidelines
From - Laboratory Industry Report
Exact Sciences' molecular colorectal cancer test will be included in the National Committee for Quality Assurance's (NCQA) updated guidelines for screening for…
Trovagene, University of Michigan Enter Pact to Focus on KRAS-Based Pancreatic Cancer Detection, Treatment
From - Laboratory Industry Report
Trovagene has entered into a pact with the University of Michigan Comprehensive Cancer Center in order to develop a molecular test for the earlier detection and…
AMP Examines Costs for Genomic Sequencing
...
Already a member? Log in here
Walgreens Terminates Contract With Theranos
...
Already a member? Log in here
Quest Expands Testing Site Deal With Safeway
...
Already a member? Log in here
Grifols Takes 20 percent Stake in Singulex
...
Already a member? Log in here